Abbonarsi

Heritable risk for severe anaphylaxis associated with increased ?-tryptase–encoding germline copy number at TPSAB1 - 04/02/21

Doi : 10.1016/j.jaci.2020.06.035 
Jonathan J. Lyons, MD a, , Jack Chovanec, BS a, Michael P. O’Connell, PhD a, Yihui Liu, PhD a, Julij Šelb, MD, PhD b, Roberta Zanotti, MD c, Yun Bai, PhD a, Jiwon Kim, BS a, Quang T. Le, PhD d, Tom DiMaggio, ADN a, Lawrence B. Schwartz, MD, PhD d, Hirsh D. Komarow, MD a, Matija Rijavec, PhD b, Melody C. Carter, MD a, Joshua D. Milner, MD e, , Patrizia Bonadonna, MD f, , Dean D. Metcalfe, MD a, , Peter Korošec, PhD b,
a Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md 
b University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia 
c Department of Medicine, Section of Hematology, Verona, Italy 
d Department of Internal Medicine, Virginia Commonwealth University, Richmond, Va 
e Division of Allergy, Immunology and Rheumatology, Columbia University, New York, New York 
f Allergy Unit, Verona University Hospital, Verona, Italy 

Corresponding author: Jonathan J. Lyons, MD, 9000 Rockville Pike, Building 29B, Room 5NN18, National Institutes of Health, Bethesda, MD 20892-1881.9000 Rockville PikeBuilding 29BRoom 5NN18National Institutes of HealthBethesdaMD20892-1881

Abstract

Background

An elevated basal serum tryptase level is associated with severe systemic anaphylaxis, most notably caused by Hymenoptera envenomation. Although clonal mast cell disease is the culprit in some individuals, it does not fully explain this clinical association.

Objective

Our aim was to determine the prevalence and associated impact of tryptase genotypes on anaphylaxis in humans.

Methods

Cohorts with systemic mastocytosis (SM) and venom as well as idiopathic anaphylaxis from referral centers in Italy, Slovenia, and the United States, underwent tryptase genotyping by droplet digital PCR. Associated anaphylaxis severity (Mueller scale) was subsequently examined. Healthy volunteers and controls with nonatopic disease were recruited and tryptase was genotyped by droplet digital PCR and in silico analysis of genome sequence, respectively. The effects of pooled and recombinant human tryptases, protease activated receptor 2 agonist and antagonist peptides, and a tryptase-neutralizing mAb on human umbilical vein endothelial cell permeability were assayed using a Transwell system.

Results

Hereditary α-tryptasemia (HαT)—a genetic trait caused by increased α-tryptase–encoding Tryptase-α/β1 (TPSAB1) copy number resulting in elevated BST level—was common in healthy individuals (5.6% [n = 7 of 125]) and controls with nonatopic disease (5.3% [n = 21 of 398]). HαT was associated with grade IV venom anaphylaxis (relative risk = 2.0; P < .05) and more prevalent in both idiopathic anaphylaxis (n = 8 of 47; [17%; P = .006]) and SM (n = 10 of 82 [12.2%; P = .03]) relative to the controls. Among patients with SM, concomitant HαT was associated with increased risk for systemic anaphylaxis (relative risk = 9.5; P = .007). In vitro, protease-activated receptor-2–dependent vascular permeability was induced by pooled mature tryptases but not α- or β-tryptase homotetramers.

Conclusions

Risk for severe anaphylaxis in humans is associated with inherited differences in α-tryptase–encoding copies at TPSAB1.

Il testo completo di questo articolo è disponibile in PDF.

Graphical abstract




Il testo completo di questo articolo è disponibile in PDF.

Key words : Mastocytosis, venom, hypersensitivity, idiopathic anaphylaxis, mast cell activation, hereditary α-tryptasemia

Abbreviations used : ADGRE2, BM, BST, ddPCR, EGM-2, HαT, HUVEC, HVA, IA, NIH, PAR, PAR-2, pNA, RR, SM, TPSAB1, TPSB2, TPSD1


Mappa


 Supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
 Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.


© 2020  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 147 - N° 2

P. 622-632 - Febbraio 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Gut microbiota development during infancy: Impact of introducing allergenic foods
  • Tom Marrs, Jay-Hyun Jo, Michael R. Perkin, Damian W. Rivett, Adam A. Witney, Kenneth D. Bruce, Kirsty Logan, Joanna Craven, Suzana Radulovic, Serge A. Versteeg, Ronald van Ree, W. H. Irwin McLean, David P. Strachan, Gideon Lack, Heidi H. Kong, Carsten Flohr
| Articolo seguente Articolo seguente
  • Cardiovascular changes during peanut-induced allergic reactions in human subjects
  • Monica Ruiz-Garcia, Joan Bartra, Olaya Alvarez, Ashna Lakhani, Shalinee Patel, Alistair Tang, Marcus Sim, Mohamed H. Shamji, Isabel Skypala, E. N. Clare Mills, Alexander R. Lyon, Carl Hayward, Stephen R. Durham, Paul J. Turner, Robert J. Boyle

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.